- Home
- LEE vs NVNO Comparison
LEE vs NVNO Comparison
Compare LEE & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEE
- NVNO
- Stock Information
- Founded
- LEE 1890
- NVNO 1987
- Country
- LEE United States
- NVNO United States
- Employees
- LEE N/A
- NVNO N/A
- Industry
- LEE Newspapers/Magazines
- NVNO Medical/Dental Instruments
- Sector
- LEE Consumer Discretionary
- NVNO Health Care
- Exchange
- LEE Nasdaq
- NVNO Nasdaq
- Market Cap
- LEE 53.6M
- NVNO 61.9M
- IPO Year
- LEE N/A
- NVNO N/A
- Fundamental
- Price
- LEE $8.50
- NVNO $2.45
- Analyst Decision
- LEE
- NVNO
- Analyst Count
- LEE 0
- NVNO 0
- Target Price
- LEE N/A
- NVNO N/A
- AVG Volume (30 Days)
- LEE 17.3K
- NVNO 94.7K
- Earning Date
- LEE 05-01-2025
- NVNO 05-07-2025
- Dividend Yield
- LEE N/A
- NVNO N/A
- EPS Growth
- LEE N/A
- NVNO N/A
- EPS
- LEE N/A
- NVNO N/A
- Revenue
- LEE $600,264,000.00
- NVNO N/A
- Revenue This Year
- LEE N/A
- NVNO N/A
- Revenue Next Year
- LEE N/A
- NVNO $409.09
- P/E Ratio
- LEE N/A
- NVNO N/A
- Revenue Growth
- LEE N/A
- NVNO N/A
- 52 Week Low
- LEE $7.57
- NVNO $2.03
- 52 Week High
- LEE $19.63
- NVNO $6.48
- Technical
- Relative Strength Index (RSI)
- LEE 38.41
- NVNO 44.81
- Support Level
- LEE $8.23
- NVNO $2.05
- Resistance Level
- LEE $9.90
- NVNO $2.44
- Average True Range (ATR)
- LEE 0.67
- NVNO 0.23
- MACD
- LEE -0.09
- NVNO 0.02
- Stochastic Oscillator
- LEE 10.19
- NVNO 53.42
About LEE Lee Enterprises Incorporated
Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).